metformin has been researched along with 8-(4-sulfophenyl)theophylline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davidson, SM; Gonçalves, L; Hausenloy, DJ; Mocanu, MM; Monteiro, P; Paiva, M; ProvidĂȘncia, L; Riksen, NP; Rongen, GA; Smits, P; Yellon, DM | 1 |
1 other study(ies) available for metformin and 8-(4-sulfophenyl)theophylline
Article | Year |
---|---|
Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.
Topics: Adenosine; Animals; Biological Transport; Hypoglycemic Agents; In Vitro Techniques; Male; Metformin; Myocardial Infarction; Myocardial Reperfusion Injury; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Theophylline; Thioinosine | 2009 |